As of 2025-07-03, the Relative Valuation of Zentalis Pharmaceuticals Inc (ZNTL) is (84.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.24 USD, the upside of Zentalis Pharmaceuticals Inc based on Relative Valuation is -6909.7%.
The range of the Relative Valuation is (68.11) - (91.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.4x - 31.0x | 26.9x |
| Forward P/E multiples | 21.9x - 29.4x | 27.3x |
| Fair Price | (68.11) - (91.54) | (84.44) |
| Upside | -5593.0% - -7482.6% | -6909.7% |
| Date | P/E |
| 2025-06-27 | -0.38 |
| 2025-06-26 | -0.40 |
| 2025-06-25 | -0.42 |
| 2025-06-24 | -0.43 |
| 2025-06-23 | -0.42 |
| 2025-06-20 | -0.42 |
| 2025-06-18 | -0.44 |
| 2025-06-17 | -0.48 |
| 2025-06-16 | -0.48 |
| 2025-06-13 | -0.43 |
| 2025-06-12 | -0.47 |
| 2025-06-11 | -0.47 |
| 2025-06-10 | -0.52 |
| 2025-06-09 | -0.48 |
| 2025-06-06 | -0.49 |
| 2025-06-05 | -0.47 |
| 2025-06-04 | -0.48 |
| 2025-06-03 | -0.44 |
| 2025-06-02 | -0.41 |
| 2025-05-30 | -0.39 |
| 2025-05-29 | -0.40 |
| 2025-05-28 | -0.40 |
| 2025-05-27 | -0.39 |
| 2025-05-23 | -0.39 |
| 2025-05-22 | -0.40 |
| 2025-05-21 | -0.39 |
| 2025-05-20 | -0.41 |
| 2025-05-19 | -0.40 |
| 2025-05-16 | -0.40 |
| 2025-05-15 | -0.40 |
| 2025-05-14 | -0.38 |
| 2025-05-13 | -0.39 |
| 2025-05-12 | -0.41 |
| 2025-05-09 | -0.39 |
| 2025-05-08 | -0.40 |
| 2025-05-07 | -0.39 |
| 2025-05-06 | -0.40 |
| 2025-05-05 | -0.44 |
| 2025-05-02 | -0.47 |
| 2025-05-01 | -0.47 |
| 2025-04-30 | -0.46 |
| 2025-04-29 | -0.44 |
| 2025-04-28 | -0.46 |
| 2025-04-25 | -0.46 |
| 2025-04-24 | -0.48 |
| 2025-04-23 | -0.48 |
| 2025-04-22 | -0.47 |
| 2025-04-21 | -0.44 |
| 2025-04-17 | -0.41 |
| 2025-04-16 | -0.40 |